The 3rd annual Immuno-Oncology 360° event, brought to you by Conference Forum, is taking place February 1-3, 2017 in NYC. Designed by lead Advisors Dr Axel Hoos (GSK) and Dr James Gulley (NCI) the program provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated.
It features guest speakers:
|
Co-Chair Axel Hoos, MD, PhD |
Co-Chair James Gulley, MD, PhD NCI |
Keynote James Allison, PhD |
With rapid development of cancer immunotherapy drug development, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce. The science behind immune-based therapies is driving rapid change. Both small and large companies are racing to bring game-changing therapies to the market and in many cases, partnering to maximize on combination therapies. As a result, innovative approaches and developments are also creating increased momentum for investment/business development opportunities.
Check out the following links for more information:
